U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Prevent an increase in the proportion of macrolide antibiotic-resistant Campylobacter infections — FS‑06

Status: Baseline only

  
Baseline only
Learn more about our data release schedule

Most Recent Data:
2.0 percent (2016-18)

Target:
2.0 percent 1

Desired Direction:
Maintains

Baseline:
2.0 percent of domestically-acquired Campylobacter jejuni infections in humans were resistant to macrolides in 2016-18 2

See detailed data for this objective

Prevent an increase in the proportion of domestically-acquired Campylobacter jejuni infections in humans that are resistant to macrolides

Target-Setting Method
Maintain the baseline

Data Sources:  National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS), CDC/NCEZID; Foodborne Diseases Active Surveillance Network (FoodNet), CDC/NCEZID

Learn more about data measurement for this objective

Summary

Campylobacter jejuni is one of the major causes of foodborne illness in the United States, and antibiotic treatment is recommended for severe infections. Every year, many people get Campylobacter jejuni infections that are resistant to the macrolide class of antibiotics. Careful use of macrolide antibiotics and strategies that reduce antibiotic-resistant Campylobacter in animals raised for food are critical for preventing macrolide antibiotic-resistant Campylobacter jejuni infections in humans.

Topics:  Foodborne Illness, Community, Health Care

Workgroup: Food Safety Workgroup

Other objectives you may be interested in

Browse all Healthy People 2030 objectives

1. Target has been revised. See Data Methodology and Measurement for more information.

2. Baseline has been revised. See Data Methodology and Measurement for more information.